Metabolic therapies are being explored for a wide range of mental health conditions, particularly serious mental illnesses. At Metabolic Mind, the primary focus is on conditions such as major depressive disorder, bipolar disorder, schizophrenia, schizoaffective disorder, and anorexia nervosa.
Research and clinical perspectives, including those outlined by Dr. Chris Palmer in his book Brain Energy, suggest that if mental illness is linked to metabolic and mitochondrial dysfunction in the brain, then many psychiatric conditions may potentially benefit from metabolic approaches.
According to Dr. Palmer, the scientific literature has identified mitochondrial dysfunction in the following psychiatric conditions:
- schizophrenia
- schizoaffective disorder
- bipolar disorder
- major depression
- autism
- anxiety disorders
- obsessive-compulsive disorder (OCD)
- post-traumatic stress disorder (PTSD)
- attention deficit/hyperactivity disorder (ADHD)
- anorexia nervosa
- alcohol use disorder (alcoholism)
- marijuana use disorder
- opioid use disorder
- borderline personality disorder
- Alzheimer’s disease
Additionally, the field of metabolic neurology is expanding, with clinicians such as Dr. Matthew Phillips and researchers such as Steven Cunnane exploring metabolic therapies for neurodegenerative disorders, including dementia, Parkinson’s disease, ALS, and Huntington’s disease. In our expert by experience stories featured in THINK+SMART, you will find individuals across a wide range of psychiatric and neurological conditions who report meaningful improvements with metabolic therapies.